跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18 条关于
“RareSight”
全部
18
临床试验
8
药物
0
机构
1
资讯
9
10个月前
PolyActiva and RareSight Partner to Develop First-in-Class Treatments for Rare Pediatric Retinal Diseases
去年
FarrSight-Twin Digital Twins Accurately Replicate Cancer Clinical Trial Outcomes
去年
Allogene and Foresight Diagnostics Forge $37.3M Partnership for Lymphoma Diagnostic Development
9个月前
Foresight Diagnostics Showcases Ultrasensitive MRD Technology in Multiple Lymphoma Studies at ASH 2025
9个月前
Natera Acquires Foresight Diagnostics for $275 Million to Advance Molecular Residual Disease Detection
去年
Foresight Diagnostics Sets Strategic Goals for 2025 Following a Year of Significant Achievements
8个月前
CDT Equity Partners with NJS Foresight Bio-Advisory to Accelerate Solid-Form Patent Out-Licensing
去年
QIAGEN Partners with Foresight Diagnostics and Tracer Biotechnologies to Expand Minimal Residual Disease Testing Portfolio
去年
Foresight Diagnostics and Roche Resolve Patent Dispute with PhasED-Seq Licensing Agreement for Non-Hodgkin's Lymphoma Diagnostics